323 results on '"Dammacco, Franco"'
Search Results
2. Gene Fusion in NSCLC
3. Bone Metastases from Solid Tumors
4. Preface
5. List of Contributors
6. Cancer Stem Cells in Multiple Myeloma and the Development of Novel Therapeutic Strategies
7. From the Double Helix to Oncogenomics and Precision Cancer Medicine
8. Supplementary Figure 3 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
9. Supplementary Figure 5 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
10. Supplementary Figure 1 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
11. Supplementary Table 2 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
12. Supplementary Data from Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma
13. Supplementary Data from Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma
14. Supplementary Figure S1 from Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
15. Supplementary Figure 2 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
16. Supplementary Data from Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
17. Supplementary Methods, Figure Legend from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
18. Supplementary Figure 4 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
19. Supplementary Figure 4 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
20. Supplementary Figure 5 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
21. Supplementary Methods, Figure Legend from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
22. Supplementary Figure S1 from Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
23. Supplementary Table 1 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
24. Supplementary Figure 1 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
25. Supplementary Table 2 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
26. Supplementary Figure 2 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
27. Supplementary Table 1 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
28. Supplementary Data from Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
29. Supplementary Figure 3 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
30. Supplementary Table 2 from β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
31. Supplementary Table 1 from β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
32. Data from β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
33. Supplementary Table 2 from β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
34. Data from β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
35. Supplementary Table 1 from β3 Integrin Subunit Mediates the Bone-Resorbing Function Exerted by Cultured Myeloma Plasma Cells
36. STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure
37. The eye is a common site of granulomatosis with polyangiitis. A collaborative study
38. Ocular Manifestations of Cryoglobulinemia: a Reappraisal
39. Ocular Manifestations in an Italian Cohort of Patients with Takayasu Arteritis
40. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements
41. Granulomatosis with Polyangiitis (Wegener’s)
42. HCV-Related Cryoglobulinemic Vasculitis: An Overview
43. Animal Models of ANCA-Associated Vasculitides
44. Microscopic Polyangiitis
45. Vasculitis in Connective Tissue Diseases
46. Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review
47. Highlights in clinical medicine—Giant cell arteritis, polymyalgia rheumatica and Takayasu’s arteritis: pathogenic links and therapeutic implications
48. The Spectrum of Ocular Manifestations in Patients with Waldenström’s Macroglobulinemia
49. The Pivotal Role of C1qR in Mixed Cryoglobulinemia
50. Introductory Remarks
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.